Radiation and immunotherapy combo tested for stubborn lymphoma
NCT ID NCT04827862
Summary
This study is testing whether adding low-dose radiation to an immunotherapy drug (pembrolizumab) can help control non-Hodgkin lymphoma that has come back or stopped responding to other treatments. It is for adults whose cancer has progressed after at least two prior therapies. The goal is to see if this combination can shrink tumors and keep the disease under control for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Abamson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.